Forest Laboratories Names Karen L. Ling Senior Vice President, Chief Human Resources Officer
January 10 2014 - 9:15AM
Business Wire
Forest Laboratories, Inc. (NYSE:FRX) today announced that Karen
Ling was appointed Senior Vice President and Chief Human Resources
Officer. In this role, Ms. Ling will be responsible for leading the
human resources organization, including talent management,
leadership development, compensation & benefits, and staffing.
Ms. Ling will report to Brent Saunders, Chief Executive Officer and
President, and serve as a member of the Forest Executive Team upon
joining the company on January 21, 2014. Ms. Ling succeeds Sally
Paull, who joined Forest in 2009 and served as the company’s Senior
Vice President of Human Resources.
Commenting on the appointment of Ms. Ling to this new position,
Mr. Saunders said, “Karen brings to Forest extensive global human
resources experience in pharmaceuticals and consumer health care.
She is a strong business leader whose experience includes advising
boards of directors on compensation and benefits-related matters,
merger integration, and leading the human resources activities for
commercial organizations with more than $40 billion in revenue and
operations in more than 100 countries. As we continue to rejuvenate
Forest, Ms. Ling’s skills and breadth of experience will be
essential for Forest to retain, develop, and attract a
best-in-class workforce capable of adapting to a changing
environment.”
“I thank Sally for her outstanding service to Forest
Laboratories. During her tenure, Sally transformed the human
resources function, building its ability to support critical
business strategies. Her leadership, global experience, and sound
counsel to executive management strengthened all facets of the
company’s talent infrastructure and created a strong platform for
the Company’s next generation of growth,” said Mr. Saunders.
Ms. Ling most recently was Senior Vice President, Human
Resources, for Merck & Co., Inc.’s Global Human Health and
Consumer Care businesses worldwide. Prior to that role at Merck,
she was Vice President, Compensation and Benefits. Prior to Merck,
Ms. Ling was Group Vice President, Global Compensation &
Benefits at Schering-Plough.
Ms. Ling spent 14 years at Wyeth in various positions of
responsibility in human resources for the pharmaceutical, vaccines,
and consumer health commercial businesses. She also worked in Wyeth
Pharmaceutical’s Labor and Employment Department.
Prior to joining Wyeth, Ms. Ling practiced corporate law with
Goldstein and Manello, P.C. in Boston.
Ms. Ling is a graduate of Yale University, with a degree in
economics, and Boston University School of Law.
About Forest Laboratories and Its Products
Forest Laboratories (NYSE: FRX) is a leading, fully integrated,
specialty pharmaceutical company largely focused on the United
States market. The Company markets a portfolio of branded drug
products and develops new medicines to treat patients suffering
from diseases principally in five therapeutic areas: central
nervous system, cardiovascular, gastrointestinal, respiratory, and
anti-infective. Our strategy of acquiring product rights for
development and commercialization through licensing, collaborative
partnerships and targeted mergers and acquisitions allows us to
take advantage of attractive late-stage development and commercial
opportunities, thereby managing the risks inherent in drug
development. The Company is headquartered in New York, NY.
Forest Laboratories, Inc.INVESTORS:Frank J. Murdolo,
1-212-224-6714Vice President - Investor
Relationsmedia.relations@frx.comorMEDIA:Amanda KaufmanMedia
Relationsamanda.kaufman@frx.com
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024